Nurix Therapeutics, Inc. (NRIX) › Operating IncomeNurix Therapeutics, Inc. (NRIX) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2019: -$22.24M2020: -$64.98M2021: -$117.89M2022: -$183.87M2023: -$155.06M2024: -$213.03M2025: -$285.67M-$285.67M2019Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$285.67M-34.1%2024-$213.03M-37.4%2023-$155.06M+15.7%2022-$183.87M-56.0%2021-$117.89M-81.4%2020-$64.98M-192.2%2019-$22.24M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share